CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 First Wave BioPharma, Inc. - FWBI CFD

3.0290
0.32%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.1520
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 0.001
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 3.0193
开盘价* 3.0679
1 年变化* 178.9%
日范围* 2.9795 - 3.1974
52 周范围 2.76-289.80
平均交易量（10 天） 120.97K
平均交易量（3 个月) 11.19M
市值 4.97M
市盈率 -100.00K
流通股 1.55M
收入 N/A
EPS -248.68
股息（收益率 %） N/A
贝塔 1.69
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 22, 2023 3.0193 -0.0990 -3.17% 3.1183 3.1774 2.9687
Mar 21, 2023 3.1678 0.0892 2.90% 3.0786 3.1678 3.0582
Mar 20, 2023 3.0588 0.0499 1.66% 3.0089 3.1283 2.9691
Mar 17, 2023 3.0291 0.0600 2.02% 2.9691 3.0391 2.9591
Mar 16, 2023 2.9695 0.1986 7.17% 2.7709 3.0093 2.7704
Mar 15, 2023 2.9302 0.1883 6.87% 2.7419 2.9302 2.6917
Mar 14, 2023 2.7715 -0.1685 -5.73% 2.9400 2.9400 2.6912
Mar 13, 2023 3.0191 -0.5440 -15.27% 3.5631 3.5731 2.9982
Mar 10, 2023 3.6238 0.0103 0.29% 3.6135 3.6634 3.5640
Mar 9, 2023 3.7131 -0.2472 -6.24% 3.9603 4.1786 3.5639
Mar 8, 2023 3.5246 -0.0395 -1.11% 3.5641 3.6041 3.4648
Mar 7, 2023 3.5148 -0.0593 -1.66% 3.5741 3.7130 3.5047
Mar 6, 2023 3.6437 0.0800 2.24% 3.5637 3.7130 3.5637
Mar 3, 2023 3.6436 0.1790 5.17% 3.4646 3.7723 3.4646
Mar 2, 2023 3.5146 0.0496 1.43% 3.4650 3.5546 3.4650
Mar 1, 2023 3.5346 0.0200 0.57% 3.5146 3.5645 3.4650
Feb 28, 2023 3.4750 0.1891 5.75% 3.2859 3.5248 3.2856
Feb 27, 2023 3.4157 -0.2371 -6.49% 3.6528 3.7229 3.3658
Feb 24, 2023 3.6733 0.0595 1.65% 3.6138 3.7923 3.5241
Feb 23, 2023 3.7228 -0.0391 -1.04% 3.7619 3.7924 3.6632

First Wave BioPharma, Inc. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 0 0 0 0 0
总营业费用 59.0569 26.8313 14.7437 13.4318 10.2212
销售/一般/行政费用，总计 18.3696 7.27976 6.04227 8.17431 6.93171
研究与开发 38.3204 19.105 7.85849 4.98555 2.39548
Depreciation / Amortization 0.015 0.048 0.84299 0.06191 0.754
Other Operating Expenses, Total 0 0.21 0.14
营业收入 -59.0569 -26.8313 -14.7437 -13.4318 -10.2212
利息收入（费用），非经营净值 -0.01007 -5.84013 -0.43394 -0.10185 -0.8752
其他，净值 0.5291 0
税前净收入 -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
税后净收入 -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
未计算非常项目前的净收益 -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
净收入 -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
普通股股东可获收益 (不含非经常性项目) -84.5186 -41.7323 -15.1777 -13.5336 -11.0964
普通股股东可获收益 (含非經常性項目) -84.5186 -41.7323 -15.1777 -13.5336 -11.0964
摊薄净收入 -84.5186 -41.7323 -15.1777 -13.5336 -11.0964
摊薄后加权平均股 8.92573 2.84363 2.24256 1.54393 1.06288
扣除特别项目的每股摊薄盈利 -9.4691 -14.6757 -6.76803 -8.76569 -10.4399
每股正常摊薄盈利 -9.20559 -14.5356 -6.76803 -8.76569 -10.4399
收入 0
异常费用（收入） 2.35199 0.39857
Total Adjustments to Net Income -25.9807 -9.06087
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
总营业费用 9.38207 11.167 30.3995 9.27689 8.21354
销售/一般/行政费用，总计 4.40556 3.03678 6.02116 3.62809 5.69751
研究与开发 4.97652 5.77821 24.3783 5.6468 2.51503
Depreciation / Amortization 0.002 0.001
营业收入 -9.38207 -11.167 -30.3995 -9.27689 -8.21354
利息收入（费用），非经营净值 -0.00547 -0.00123 -0.00074 -0.00295 -0.00474
其他，净值 -0.2393 -0.00428 -0.00057 0.0009 0.53265
税前净收入 -9.62684 -11.1725 -30.4008 -9.27894 -7.68563
税后净收入 -9.62684 -11.1725 -30.4008 -9.27894 -7.68563
未计算非常项目前的净收益 -9.62684 -11.1725 -30.4008 -9.27894 -7.68563
净收入 -9.62684 -11.1725 -30.4008 -9.27894 -7.68563
Total Adjustments to Net Income -0.68577 -0.11623 -0.11809 -3.45087 -22.2956
普通股股东可获收益 (不含非经常性项目) -10.3126 -11.2887 -30.5189 -12.7298 -29.9812
普通股股东可获收益 (含非經常性項目) -10.3126 -11.2887 -30.5189 -12.7298 -29.9812
摊薄净收入 -10.3126 -11.2887 -30.5189 -12.7298 -29.9812
摊薄后加权平均股 15.5447 12.9223 9.34236 7.81244 5.53481
扣除特别项目的每股摊薄盈利 -0.66342 -0.87359 -3.26672 -1.62943 -5.41684
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.66342 -0.69158 -3.26672 -1.62943 -5.41684
异常费用（收入） 2.35199
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 9.42495 7.86978 3.40829 4.8 1.95257
现金和短期投资 8.24868 6.06214 0.1758 1.11434 0.57347
Cash 8.24868 6.06214 0.1758 1.11434 0.57347
短期投资
应收账款总额，净额 0 0.55149 2.6373 3.17268 1.10413
Prepaid Expenses 1.17627 1.25615 0.59519 0.51298 0.27496
Total Assets 11.79 12.9239 8.90288 7.4694 5.47967
Property/Plant/Equipment, Total - Net 0.40931 0.09257 0.15978 0.12885 0.13399
Goodwill, Net 1.91171 2.05405 1.88669 1.92483 2.01624
Intangibles, Net 0 2.87954 3.40708 0.57048 1.34596
Other Long Term Assets, Total 0.04401 0.02792 0.04105 0.04523 0.03092
Total Current Liabilities 12.3004 15.5454 4.28564 2.99552 2.47908
Payable/Accrued 0 0.53343 0.6701 2.05534
Accrued Expenses 0.49706 0.18443 0.15441 0.53829 0.00719
Notes Payable/Short Term Debt 0.64124 0.55241 1.5213 0.25503 0.41655
Other Current Liabilities, Total 8.48018 13.25 0.39299
Total Liabilities 19.6115 15.5646 4.28564 2.99552 3.81908
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 7.31114 0.01912 0 0 1.34
Total Equity -7.82155 -2.64069 4.61724 4.47387 1.66059
Common Stock 0.00149 0.00312 0.00268 0.00177 0.00121
Additional Paid-In Capital 147.305 93.8349 68.5759 53.1393 37.6696
Retained Earnings (Accumulated Deficit) -153.904 -95.3662 -62.6947 -47.5171 -33.9834
Other Equity, Total -1.22414 -1.11255 -1.26656 -1.15011 -2.02679
Total Liabilities & Shareholders’ Equity 11.79 12.9239 8.90288 7.4694 5.47967
Total Common Shares Outstanding 14.8559 3.11503 2.68005 1.77049 1.20426
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Property/Plant/Equipment, Total - Gross 0.42402 0.13097 0.4233 0.33225
Accumulated Depreciation, Total -0.01471 -0.0384 -0.26352 -0.20339
Accounts Payable 2.68191 1.55859 1.68351 1.53211
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 6.55017 9.42495 7.50249 8.61528 13.1704
现金和短期投资 5.69499 8.24868 7.21065 8.07449 12.0256
Cash 5.69499 8.24868 7.21065 8.07449 12.0256
应收账款总额，净额 0.02806 0 0 0 0.50166
Prepaid Expenses 0.82713 1.17627 0.29184 0.54079 0.64313
Total Assets 8.82544 11.79 12.424 13.7768 17.9829
Property/Plant/Equipment, Total - Net 0.3788 0.40931 0.44889 0.48488 0.06162
Property/Plant/Equipment, Total - Gross 0.40083 0.42402 0.45632 0.4861 0.0812
Accumulated Depreciation, Total -0.02203 -0.01471 -0.00743 -0.00123 -0.01958
Goodwill, Net 1.86207 1.91171 1.94474 1.99129 1.97396
Intangibles, Net 0 2.48388 2.61576 2.74765
Other Long Term Assets, Total 0.0344 0.04401 0.04403 0.0696 0.02924
Total Current Liabilities 14.2157 12.3004 19.0983 6.45412 3.57464
Accounts Payable 3.44993 2.68191 18.4478 4.44991 1.44072
Accrued Expenses 0.7883 0.49706 0.22987 0.31246 0.32383
Notes Payable/Short Term Debt 0.40277 0.64124 0 0.13957 0.34708
Other Current Liabilities, Total 9.57473 8.48018 0.42063 1.55218 1.46302
Total Liabilities 18.0652 19.6115 19.394 6.73988 3.58121
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 3.8495 7.31114 0.29569 0.28575 0.00657
Total Equity -9.23979 -7.82155 -6.96999 7.03692 14.4017
Common Stock 0.00215 0.00149 0.00111 0.00826 0.00749
Additional Paid-In Capital 155.571 147.305 137.028 120.585 118.693
Retained Earnings (Accumulated Deficit) -163.531 -153.904 -142.732 -112.331 -103.052
Other Equity, Total -1.28254 -1.22414 -1.26711 -1.2255 -1.24734
Total Liabilities & Shareholders’ Equity 8.82544 11.79 12.424 13.7768 17.9829
Total Common Shares Outstanding 21.5488 14.8559 11.1152 8.25851 7.49269
Preferred Stock - Non Redeemable, Net 0
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -58.5378 -32.6715 -15.1777 -13.5336 -11.0964
经营活动产生的现金 -32.2882 -11.2215 -14.0335 -10.8693 -7.18464
经营活动产生的现金 0.01471 0.0378 0.0631 0.06191 0.04952
Amortization 0.52755 0.52755 0.95695 0.73654 0.70448
非现金物品 8.60641 6.73365 1.82513 3.57765 3.42595
营运资金的变化 17.101 14.1509 -1.70099 -1.7118 -0.26821
投资活动产生的现金 -10.3195 0.08735 -0.0241 -0.30547 -0.03217
资本支出 -0.06949 -0.00417 -0.0241 -0.30547 -0.03217
融资活动产生的现金 44.7635 17.0461 13.145 11.7121 6.01322
融资现金流项目 0
股票的发行（报废），净额 44.6747 14.1861 9.53834 11.9028 5.00923
债务的发行（退还），净额 0.08883 2.86003 3.60664 -0.19068 1.00399
外汇效应 0.03076 -0.02559 -0.02593 0.00354 0.00353
现金净变化 2.18654 5.88635 -0.93855 0.54087 -1.20005
Cash Taxes Paid 0 0 0 0
已付现金利息 0 0.10546 0.00803 0.00401 0.00415
其他投资现金流量项目，总计 -10.25 0.09152
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -9.62684 -58.5378 -47.3654 -16.9646 -7.68563
Cash From Operating Activities -7.91207 -32.2882 -26.4254 -10.6961 -5.07339
Cash From Operating Activities 0.00732 0.01471 0.00939 0.00301 0.00102
Amortization 0 0.52755 0.39566 0.26377 0.13189
Non-Cash Items 0.36042 8.60641 2.04186 1.7359 1.80638
Cash Interest Paid 0 0 0 0 0.00514
Changes in Working Capital 1.34703 17.101 18.493 4.26576 0.67294
Cash From Investing Activities -10.3195 -10.3215 -9.07393 0
Capital Expenditures -0.06949 -0.07145 -0.07393 0
Cash From Financing Activities 5.36715 44.7635 37.9406 21.8326 11.0506
Financing Cash Flow Items -2.41496 -9.53235
Issuance (Retirement) of Stock, Net 8.02057 44.6747 38.493 22.2454 20.7883
Issuance (Retirement) of Debt, Net -0.23847 0.08883 -0.55241 -0.41284 -0.20532
Foreign Exchange Effects -0.00877 0.03076 -0.04525 -0.05019 -0.01374
Net Change in Cash -2.5537 2.18654 1.1485 2.01235 5.96349
Cash Taxes Paid 0 0 0
Other Investing Cash Flow Items, Total -10.25 -10.25 -9
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Sapirstein (James E) Individual Investor 4.3072 42857 42857 2023-01-03 HIGH
Armistice Capital LLC Hedge Fund 4.2206 41995 41995 2022-12-31 HIGH
Romano (Sarah M.) Individual Investor 2.1537 21429 21429 2023-01-03 MED
Hoffman (David Andrew) Individual Investor 1.3033 12968 12106 2023-01-03 HIGH
Borkowski (Edward J) Individual Investor 1.237 12308 12106 2023-01-03
Riddell (Alastair) Individual Investor 1.223 12169 12106 2023-01-03
Casamento (Charles J) Individual Investor 1.2223 12162 12106 2023-01-03
Coelho (Mary Theresa) Individual Investor 1.2167 12106 12106 2023-01-03 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.1858 11799 0 2022-12-31 LOW
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.7214 7178 7178 2022-12-31 MED
Susquehanna International Group, LLP Investment Advisor 0.2193 2182 2182 2022-12-31 MED
UBS Financial Services, Inc. Investment Advisor 0.2048 2038 1752 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.1537 1529 1529 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.0982 977 0 2023-02-28 LOW
Tower Research Capital LLC Hedge Fund 0.0975 970 497 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.0379 377 0 2022-12-31 LOW
Advisor Group, Inc Investment Advisor 0.0287 286 286 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.0027 27 0 2022-12-31 LOW
U.S. Bancorp Asset Management, Inc. Investment Advisor 0.0024 24 0 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.0022 22 0 2022-12-31 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

First Wave BioPharma, Inc. Company profile

关于 First Wave BioPharma Inc.

第一波生物制药公司，前身是AzurRx生物制药公司，是一家临床阶段的生物制药公司。 它从事胃肠道（GI）疾病的靶向、非系统疗法的开发。 该公司专注于推进围绕其两项技术建立的治疗开发管道：尼可刹米，一种具有抗病毒和抗炎特性的口服小分子，以及生物制剂adrulipase，一种重组脂肪酶，旨在使脂肪和其他营养物质得到消化。 公司的烟酰胺产品组合由三个临床项目主导。 FW-COV，治疗COVID-19胃肠道感染；FW-UP，治疗溃疡性直肠炎（UP）和溃疡性直肠乙状结肠炎；FW-ICI-AC，治疗晚期肿瘤患者的1级和2级免疫检查点抑制剂相关的结肠炎和腹泻。 该公司还在推进FW-EPI（阿曲酶），用于治疗囊性纤维化和慢性胰腺炎患者的外分泌胰腺功能不全（EPI）。

Industry: Biotechnology & Medical Research (NEC)

777 Yamato Road
Suite 502
BOCA RATON
FLORIDA 33431
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,987.42 Price
+0.930% 1D Chg, %
多头隔夜费 -0.0086%
空头隔夜费 0.0004%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

12,846.20 Price
+2.190% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

BTC/USD

28,649.25 Price
+4.140% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 66.00

Oil - Crude

71.18 Price
+1.600% 1D Chg, %
多头隔夜费 -0.0170%
空头隔夜费 -0.0050%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易